These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20519942)

  • 1. Id2 gene is a transcriptional target of the protein complex mutant p53/E2F1.
    Fontemaggi G; Dell'Orso S; Muti P; Blandino G; Strano S
    Cell Cycle; 2010 Jun; 9(12):2464-6. PubMed ID: 20519942
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.
    Yan W; Liu G; Scoumanne A; Chen X
    Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.
    Fontemaggi G; Dell'Orso S; Trisciuoglio D; Shay T; Melucci E; Fazi F; Terrenato I; Mottolese M; Muti P; Domany E; Del Bufalo D; Strano S; Blandino G
    Nat Struct Mol Biol; 2009 Oct; 16(10):1086-93. PubMed ID: 19783986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 enhances 8-chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells.
    Duan HY; Cao JX; Qi JJ; Wu GS; Li SY; An GS; Jia HT; Cai WW; Ni JH
    Biochemistry (Mosc); 2012 Mar; 77(3):261-9. PubMed ID: 22803943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.
    Malaney P; Palumbo E; Semidey-Hurtado J; Hardee J; Stanford K; Kathiriya JJ; Patel D; Tian Z; Allen-Gipson D; Davé V
    Cell Cycle; 2018; 17(8):947-962. PubMed ID: 29108454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a Tip60/E2F1/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin.
    Van Den Broeck A; Nissou D; Brambilla E; Eymin B; Gazzeri S
    Carcinogenesis; 2012 Feb; 33(2):320-5. PubMed ID: 22159227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Repression of High-Mobility Group Box 2 by p21 in Radiation-Induced Senescence.
    Kim HK; Kang MA; Kim MS; Shin YJ; Chi SG; Jeong JH
    Mol Cells; 2018 Apr; 41(4):362-372. PubMed ID: 29487276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response.
    Yoshihara Y; Wu D; Kubo N; Sang M; Nakagawara A; Ozaki T
    Biochem Biophys Res Commun; 2012 Apr; 421(1):57-63. PubMed ID: 22480684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
    Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of functional domains necessary for mutant p53 gain of function.
    Yan W; Chen X
    J Biol Chem; 2010 May; 285(19):14229-38. PubMed ID: 20212049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
    Yan W; Chen X
    Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
    Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
    Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
    Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
    J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.